Rapid_development_of_resistance_to_antifolates_in_vitro:_possible_clinical_implication._Within_three_repeated_7-day_incubation_periods_with_either_methotrexate_(MTX)_or_trimetrexate_(TMTX),_human_colon_adenocarcinoma_cells_(HCT-8)_developed_high_levels_of_resistance_to_these_drugs,_as_evidenced_by_approximately_20-_and_50-fold_increases,_respectively,_in_the_median_effective_doses._Similarly,_within_six_short-term_exposures_(4_hours)_to_the_same_drugs,_a_high_degree_of_resistance_developed_in_the_cells._Alternating_4-hour_treatment_cycles_with_MTX_and_TMTX_did_not_delay_the_onset_of_resistance_to_these_antimetabolites_in_the_HCT-8_cells._The_same_strategy_produced_no_better_results_than_giving_either_MTX_or_TMTX_alone_to_(C57BL/6_x_DBA/2)F1_mice_bearing_murine_leukemia_P388_cells._Furthermore,_HCT-8_cells_resistant_to_short-term_(4-hour)_exposure_to_MTX_were_cross-resistant_to_the_same_drug_given_for_7_days_continuously,_and_cells_resistant_to_MTX_given_continuously_for_7_days_were_cross-resistant_to_the_same_drug_given_for_4_hours._Analogous_results_were_obtained_with_TMTX,_indicating_that,_under_these_circumstances,_changing_the_schedule_of_administration_of_the_same_agent_does_not_overcome_resistance_to_it._The_clinical_relevance_of_these_data_to_prolonged_adjuvant_chemotherapy,_as_well_as_loco-regional_and_continuous-infusion_chemotherapy,_is_discussed.